Arie Belldegrun

Affiliations

  • at Kronos Bio Inc. (KRON), 2025-06-20
  • Director at Allogene Therapeutics Inc. (ALLO), 2025-01-29
  • Director at Urogen Pharma Ltd. (URGN), 2024-08-08
  • Director at Ginkgo Bioworks Holdings Inc. (DNA), 2024-06-14
  • Chairman, President And Ceo at Kite Pharma Inc. (KITE), 2017-10-06
  • Director at Arno Therapeutics Inc (ARNI), 2016-08-17
  • Director at Nile Therapeutics Inc. (NLTX), 2011-05-12
  • Director at Cougar Biotechnology Inc. (CGRB), 2009-07-07
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ALLO $2.90 1,724,137 $4,999,997.30 1,724,137 2024-05-16 Filing
ALLO $12.60 155,039 $1,953,491.40 195,039 2022-01-12 Filing
ALLO $47.00 106,382 $4,999,954.00 1,798,163 2020-06-04 Filing
ALLO $47.00 40,000 $1,880,000.00 40,000 2020-06-04 Filing
ALLO $18.00 194,445 $3,500,010.00 1,691,781 2018-10-15 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KITE $179.66 26,347 $4,733,604.77 109,160 2017-09-25 Filing
KITE $50.86 3,493 $177,653.98 24,707 2016-12-20 Filing